We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
401
DELISTED
Kellanova
K
| $18.2M | 0.05% |
299,411
-9,691
| -3% | -$615K |
|
|
TRIT
402
DELISTED
Triterras, Inc. Class A Ordinary Shares
TRIT
| $18.1M | 0.05% |
+1,749,972
| New | +$18.4M |
|
403
Domino's
DPZ
$11.6B
| $18.1M | 0.05% |
42,573
-1,400
| -3% | -$557K |
|
|
CLII.U
404
DELISTED
Climate Change Crisis Real Impact I Acquisition Corporation Units, each consisting of one share of C
CLII.U
| $18.1M | 0.05% |
+1,800,000
| New | +$18.1M |
|
|
CVET
405
DELISTED
Covetrus, Inc. Common Stock
CVET
| $18.1M | 0.05% |
740,000
-360,000
| -33% | -$7.76M |
|
|
AZEK
406
DELISTED
The AZEK Co
AZEK
| $18M | 0.05% |
517,951
-182,049
| -26% | -$6.34M |
|
|
ALUS
407
DELISTED
Alussa Energy Acquisition Corp
ALUS
| $17.9M | 0.04% |
1,800,000
| – | – |
|
408
Northern Trust
NTRS
$33.8B
| $17.8M | 0.04% |
228,800
+53,500
| +31% | +$4.3M |
|
409
Valero Energy
VLO
$86.6B
| $17.7M | 0.04% |
408,600
+135,300
| +50% | +$7.09M |
|
|
VAR
410
DELISTED
Varian Medical Systems, Inc.
VAR
| $17.6M | 0.04% |
+102,099
| New | +$16.1M |
|
411
FirstEnergy
FE
$27.5B
| $17.5M | 0.04% |
610,701
-1,352
| -0.2% | -$42.4K |
|
412
CBRE Group
CBRE
$43.4B
| $17.5M | 0.04% |
372,400
-12,100
| -3% | -$552K |
|
|
TPTX
413
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $17.5M | 0.04% |
200,000
+25,000
| +14% | +$1.74M |
|
414
ResMed
RMD
$30.3B
| $17.4M | 0.04% |
101,294
-66,200
| -40% | -$12.2M |
|
415
BioNTech
BNTX
$23.3B
| $17.3M | 0.04% |
+250,000
| New | +$17.9M |
|
416
Amalgamated Financial
AMAL
$1.49B
| $17.2M | 0.04% |
1,627,645
+158,351
| +11% | +$1.85M |
|
417
Ventas
VTR
$47.7B
| $17.1M | 0.04% |
408,500
-13,600
| -3% | -$544K |
|
418
Las Vegas Sands
LVS
$29.7B
| $17.1M | 0.04% |
366,600
-11,900
| -3% | -$569K |
|
419
Old Dominion Freight Line
ODFL
$44.9B
| $16.9M | 0.04% |
187,100
+69,800
| +60% | +$6.55M |
|
420
Coherent
COHR
$73.9B
| $16.9M | 0.04% |
416,095
+184,000
| +79% | +$8.11M |
|
421
Elanco Animal Health
ELAN
$11.4B
| $16.8M | 0.04% |
+600,000
| New | +$15.2M |
|
422
Paycom
PAYC
$10B
| $16.7M | 0.04% |
53,800
-2,050
| -4% | -$599K |
|
|
AMTD
423
DELISTED
TD Ameritrade Holding Corp
AMTD
| $16.7M | 0.04% |
425,500
| – | – |
|
424
Martin Marietta Materials
MLM
$33.1B
| $16.6M | 0.04% |
70,365
-204,592
| -74% | -$44.3M |
|
425
Qorvo
QRVO
$8.7B
| $16.5M | 0.04% |
127,900
+30,800
| +32% | +$3.82M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.